Viewing Study NCT05933967


Ignite Creation Date: 2025-12-25 @ 12:52 AM
Ignite Modification Date: 2025-12-25 @ 11:07 PM
Study NCT ID: NCT05933967
Status: RECRUITING
Last Update Posted: 2023-08-15
First Post: 2023-06-16
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study of Orelabrutinib Plus R-CHOP in Treatment-naïve Patients With Double Expression Diffuse Large B-cell Lymphoma
Sponsor: Shandong Cancer Hospital and Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module